Lantheus Holdings, Inc. Total Long-Term Debt
Lantheus Holdings, Inc. (LNTH) had Total Long-Term Debt of $558.07 million as of 2022-12-31, per its 10-K filed 2023-02-23.
Discontinued › Balance Sheet › Liabilities
us-gaap:LongTermDebt · last filed 2023-02-23
- 2022-12-31: Long-term Debt $558.07M.
- 2021-12-31: Long-term Debt $174.76M.
- 2021-03-31: Long-term Debt $181.72M.
- 2020-12-31: Long-term Debt $218.40M.
| Period end | Long-term Debt |
|---|---|
| 2022-12-31 | $558.07M 10-K · filed 2023-02-23 |
| 2021-12-31 | $174.76M 10-K · filed 2022-02-24 |
| 2021-03-31 | $181.72M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $218.40M 10-K · filed 2021-02-25 |
| 2020-09-30 | $222.81M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $227.15M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $191.63M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $194.07M 10-K · filed 2020-02-25 |
| 2019-09-30 | $196.54M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $198.84M 10-Q · filed 2019-07-25 |
| 2019-03-31 | $266.15M 10-Q · filed 2019-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |